Industry
NSK Europe GmbH
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 4
2(50.0%)
N/A
2(50.0%)
4Total
Phase 4(2)
N/A(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT05264480Not ApplicableCompleted
The Introduction of a Novel PAOO Technique
Role: collaborator
NCT05005858Not ApplicableUnknown
Modified Ridge Splitting Technique Using Autogenous Bone Blocks (MRS)
Role: collaborator
NCT04854239Phase 4Completed
Accuracy of Half-guided Implant Placement
Role: collaborator
NCT04811768Phase 4Completed
Lateral Bony Wall Repositioning in Maxillary Sinus Floor Augmentation
Role: collaborator
All 4 trials loaded